Copyright Reports & Markets. All rights reserved.

Global Oncology and Cancer Treatment Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Oncology and Cancer Treatment Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Chemotherapy Drug
    • 1.3.3 Targeted Drug
    • 1.3.4 Immunotherapy Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Oncology and Cancer Treatment Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Benign Tumor
    • 1.4.3 Cancer and Other Malignant Tumors
  • 1.5 Global Oncology and Cancer Treatment Drug Market Size & Forecast
    • 1.5.1 Global Oncology and Cancer Treatment Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Oncology and Cancer Treatment Drug Sales Quantity (2021-2032)
    • 1.5.3 Global Oncology and Cancer Treatment Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Oncology and Cancer Treatment Drug Product and Services
    • 2.1.4 Roche Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Oncology and Cancer Treatment Drug Product and Services
    • 2.2.4 Novartis Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Oncology and Cancer Treatment Drug Product and Services
    • 2.3.4 Sanofi Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Oncology and Cancer Treatment Drug Product and Services
    • 2.4.4 Bayer Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments/Updates
  • 2.5 Merck & Co
    • 2.5.1 Merck & Co Details
    • 2.5.2 Merck & Co Major Business
    • 2.5.3 Merck & Co Oncology and Cancer Treatment Drug Product and Services
    • 2.5.4 Merck & Co Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck & Co Recent Developments/Updates
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Oncology and Cancer Treatment Drug Product and Services
    • 2.6.4 Eli Lilly Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Eli Lilly Recent Developments/Updates
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Oncology and Cancer Treatment Drug Product and Services
    • 2.7.4 Pfizer Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Pfizer Recent Developments/Updates
  • 2.8 Johnson & Johnson
    • 2.8.1 Johnson & Johnson Details
    • 2.8.2 Johnson & Johnson Major Business
    • 2.8.3 Johnson & Johnson Oncology and Cancer Treatment Drug Product and Services
    • 2.8.4 Johnson & Johnson Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Johnson & Johnson Recent Developments/Updates
  • 2.9 Astellas
    • 2.9.1 Astellas Details
    • 2.9.2 Astellas Major Business
    • 2.9.3 Astellas Oncology and Cancer Treatment Drug Product and Services
    • 2.9.4 Astellas Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Astellas Recent Developments/Updates
  • 2.10 AbbVie
    • 2.10.1 AbbVie Details
    • 2.10.2 AbbVie Major Business
    • 2.10.3 AbbVie Oncology and Cancer Treatment Drug Product and Services
    • 2.10.4 AbbVie Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 AbbVie Recent Developments/Updates
  • 2.11 Teva
    • 2.11.1 Teva Details
    • 2.11.2 Teva Major Business
    • 2.11.3 Teva Oncology and Cancer Treatment Drug Product and Services
    • 2.11.4 Teva Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Teva Recent Developments/Updates
  • 2.12 Otsuka
    • 2.12.1 Otsuka Details
    • 2.12.2 Otsuka Major Business
    • 2.12.3 Otsuka Oncology and Cancer Treatment Drug Product and Services
    • 2.12.4 Otsuka Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Otsuka Recent Developments/Updates
  • 2.13 Amgen
    • 2.13.1 Amgen Details
    • 2.13.2 Amgen Major Business
    • 2.13.3 Amgen Oncology and Cancer Treatment Drug Product and Services
    • 2.13.4 Amgen Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Amgen Recent Developments/Updates
  • 2.14 Yi Bai Pharmaceutical
    • 2.14.1 Yi Bai Pharmaceutical Details
    • 2.14.2 Yi Bai Pharmaceutical Major Business
    • 2.14.3 Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Product and Services
    • 2.14.4 Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Yi Bai Pharmaceutical Recent Developments/Updates
  • 2.15 Qilu Pharmaceutical
    • 2.15.1 Qilu Pharmaceutical Details
    • 2.15.2 Qilu Pharmaceutical Major Business
    • 2.15.3 Qilu Pharmaceutical Oncology and Cancer Treatment Drug Product and Services
    • 2.15.4 Qilu Pharmaceutical Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.16 Sun Pharma
    • 2.16.1 Sun Pharma Details
    • 2.16.2 Sun Pharma Major Business
    • 2.16.3 Sun Pharma Oncology and Cancer Treatment Drug Product and Services
    • 2.16.4 Sun Pharma Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Sun Pharma Recent Developments/Updates
  • 2.17 Accord Healthcare
    • 2.17.1 Accord Healthcare Details
    • 2.17.2 Accord Healthcare Major Business
    • 2.17.3 Accord Healthcare Oncology and Cancer Treatment Drug Product and Services
    • 2.17.4 Accord Healthcare Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Accord Healthcare Recent Developments/Updates
  • 2.18 SK Chemicals
    • 2.18.1 SK Chemicals Details
    • 2.18.2 SK Chemicals Major Business
    • 2.18.3 SK Chemicals Oncology and Cancer Treatment Drug Product and Services
    • 2.18.4 SK Chemicals Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 SK Chemicals Recent Developments/Updates
  • 2.19 Bristol-Myers Squibb
    • 2.19.1 Bristol-Myers Squibb Details
    • 2.19.2 Bristol-Myers Squibb Major Business
    • 2.19.3 Bristol-Myers Squibb Oncology and Cancer Treatment Drug Product and Services
    • 2.19.4 Bristol-Myers Squibb Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Bristol-Myers Squibb Recent Developments/Updates
  • 2.20 Takeda
    • 2.20.1 Takeda Details
    • 2.20.2 Takeda Major Business
    • 2.20.3 Takeda Oncology and Cancer Treatment Drug Product and Services
    • 2.20.4 Takeda Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Takeda Recent Developments/Updates
  • 2.21 Eisai
    • 2.21.1 Eisai Details
    • 2.21.2 Eisai Major Business
    • 2.21.3 Eisai Oncology and Cancer Treatment Drug Product and Services
    • 2.21.4 Eisai Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Eisai Recent Developments/Updates
  • 2.22 Biogen Idec
    • 2.22.1 Biogen Idec Details
    • 2.22.2 Biogen Idec Major Business
    • 2.22.3 Biogen Idec Oncology and Cancer Treatment Drug Product and Services
    • 2.22.4 Biogen Idec Oncology and Cancer Treatment Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.22.5 Biogen Idec Recent Developments/Updates

3 Competitive Environment: Oncology and Cancer Treatment Drug by Manufacturer

  • 3.1 Global Oncology and Cancer Treatment Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Oncology and Cancer Treatment Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global Oncology and Cancer Treatment Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Oncology and Cancer Treatment Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Oncology and Cancer Treatment Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Oncology and Cancer Treatment Drug Manufacturer Market Share in 2025
  • 3.5 Oncology and Cancer Treatment Drug Market: Overall Company Footprint Analysis
    • 3.5.1 Oncology and Cancer Treatment Drug Market: Region Footprint
    • 3.5.2 Oncology and Cancer Treatment Drug Market: Company Product Type Footprint
    • 3.5.3 Oncology and Cancer Treatment Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Oncology and Cancer Treatment Drug Market Size by Region
    • 4.1.1 Global Oncology and Cancer Treatment Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Oncology and Cancer Treatment Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global Oncology and Cancer Treatment Drug Average Price by Region (2021-2032)
  • 4.2 North America Oncology and Cancer Treatment Drug Consumption Value (2021-2032)
  • 4.3 Europe Oncology and Cancer Treatment Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Oncology and Cancer Treatment Drug Consumption Value (2021-2032)
  • 4.5 South America Oncology and Cancer Treatment Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Oncology and Cancer Treatment Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global Oncology and Cancer Treatment Drug Consumption Value by Type (2021-2032)
  • 5.3 Global Oncology and Cancer Treatment Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global Oncology and Cancer Treatment Drug Consumption Value by Application (2021-2032)
  • 6.3 Global Oncology and Cancer Treatment Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America Oncology and Cancer Treatment Drug Market Size by Country
    • 7.3.1 North America Oncology and Cancer Treatment Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Oncology and Cancer Treatment Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe Oncology and Cancer Treatment Drug Market Size by Country
    • 8.3.1 Europe Oncology and Cancer Treatment Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Oncology and Cancer Treatment Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Oncology and Cancer Treatment Drug Market Size by Region
    • 9.3.1 Asia-Pacific Oncology and Cancer Treatment Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Oncology and Cancer Treatment Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America Oncology and Cancer Treatment Drug Market Size by Country
    • 10.3.1 South America Oncology and Cancer Treatment Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Oncology and Cancer Treatment Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Oncology and Cancer Treatment Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Oncology and Cancer Treatment Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Oncology and Cancer Treatment Drug Market Size by Country
    • 11.3.1 Middle East & Africa Oncology and Cancer Treatment Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Oncology and Cancer Treatment Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Oncology and Cancer Treatment Drug Market Drivers
  • 12.2 Oncology and Cancer Treatment Drug Market Restraints
  • 12.3 Oncology and Cancer Treatment Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Oncology and Cancer Treatment Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Oncology and Cancer Treatment Drug
  • 13.3 Oncology and Cancer Treatment Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Oncology and Cancer Treatment Drug Typical Distributors
  • 14.3 Oncology and Cancer Treatment Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Oncology and Cancer Treatment Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Oncology and Cancer Treatment Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oncology and Cancer Treatment Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oncology and Cancer Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oncology and Cancer Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Oncology and Cancer Treatment Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oncology and Cancer Treatment Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oncology and Cancer Treatment Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Sanofi, Bayer, Merck & Co, Eli Lilly, Pfizer, Johnson & Johnson, Astellas, AbbVie, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Oncology and Cancer Treatment Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Chemotherapy Drug
    Targeted Drug
    Immunotherapy Drug
    Market segment by Application
    Benign Tumor
    Cancer and Other Malignant Tumors
    Major players covered
    Roche
    Novartis
    Sanofi
    Bayer
    Merck & Co
    Eli Lilly
    Pfizer
    Johnson & Johnson
    Astellas
    AbbVie
    Teva
    Otsuka
    Amgen
    Yi Bai Pharmaceutical
    Qilu Pharmaceutical
    Sun Pharma
    Accord Healthcare
    SK Chemicals
    Bristol-Myers Squibb
    Takeda
    Eisai
    Biogen Idec
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Oncology and Cancer Treatment Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Oncology and Cancer Treatment Drug, with price, sales quantity, revenue, and global market share of Oncology and Cancer Treatment Drug from 2021 to 2026.
    Chapter 3, the Oncology and Cancer Treatment Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Oncology and Cancer Treatment Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oncology and Cancer Treatment Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology and Cancer Treatment Drug.
    Chapter 14 and 15, to describe Oncology and Cancer Treatment Drug sales channel, distributors, customers, research findings and conclusion.

    Buy now